Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
8.43
-0.84 (-9.06%)
Jun 5, 2026, 3:10 PM EDT - Market open
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $617.67 million as of June 5, 2026. Its market cap has increased by 116.28% in one year.
Market Cap
617.67M
Enterprise Value
520.46M
1-Year Change
116.28%
Ranking
Category
Stock Price
$8.43
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $617.67M, an increase of 177.74%. That is a compound annual growth rate of 23.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 644.78M | 107.88% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 655.84M |
| Solid Biosciences | 647.80M |
| Aclaris Therapeutics | 646.64M |
| Tenax Therapeutics | 644.72M |
| Zevra Therapeutics | 643.17M |
| CorMedix | 640.95M |
| Design Therapeutics | 635.19M |
| SpyGlass Pharma | 613.71M |